Effect of pharmaceutical companies’ corporate reputation on drug prescribing intents in Romania

References

• Aasland, D. (2004). On the ethics behind, business ethics. Journal of Business Ethics, 53(1/2), 3–8. https://doi.org/https://doi.org/10.1023/B:BUSI.0000039395.63115.c2
   Web of Science ®Google Scholar
• Abratt, R., & Lanteigne, J. (2000). Factors influencing general practitioners in the prescription of homeopathic medicines. South African Journal of Business Management, 31(3), 91–98. https://doi.org/https://doi.org/10.4102/sajbm.v31i3.738
   Google Scholar
• Ahmed, R. R., Channar, Z. A., Soomro, R. H., Vveinhardt, J., Streimikiene, D., & Parmar, V. (2018). Antecedents of symmetry in physicians’ prescription behavior: Evidence from SEM-based multivariate approach. Symmetry, 10(12), 721. https://doi.org/https://doi.org/10.3390/sym10120721
   Google Scholar
• Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179–211. https://doi.org/https://doi.org/10.1016/0749-5978(91)90020-T
   Web of Science ®Google Scholar
• Alowi, M., & Kani, Y. (2018). Impact of pharmaceutical companies’ promotional tools on physicians’ prescription patterns: A systematic review. Journal of Applied Pharmacy, 10(3), 1–10.
   Google Scholar
• Biswas, K., & Ferdousy, U. K. (2016). Influence of pharmaceutical marketing on prescription behavior of physicians: A cross-sectional study in Bangladesh. Journal of Accounting & Marketing, 5(2), 1–4. https://doi.org/https://doi.org/10.4172/2168-9601.1000160
   Google Scholar
• Brammer, S. J., & Pavelin, S. (2006). Corporate reputation and social performance: The importance of fit. Journal of Management Studies, 43(3), 435–455. https://doi.org/https://doi.org/10.1111/j.1467-6486.2006.00597.x
   Web of Science ®Google Scholar
• Brown, M., & Mitchell, M. (2010). Ethical and unethical leadership: Exploring new avenues for future research. Business Ethics Quarterly, 20(4), 583–616. https://doi.org/https://doi.org/10.5840/beq201020439
   Web of Science ®Google Scholar
• Butterick, K. J. (2011). Introducing Public Relations Theory and Practice. SAGE.
   Google Scholar
• Carmeli, A., & Tishler, A. (2004). Resources, capabilities, and the performance of industrial firms: A multivariate analysis. Managerial and Decision Economics, 25(67), 299–315. https://doi.org/https://doi.org/10.1002/mde.1192
   Google Scholar
• Caruana, A., Cohen, C., & Krentler, K. (2006). Corporate reputation and shareholders’ intentions: An attitudinal perspective. Journal of Brand Management, 13(6), 429–440. https://doi.org/https://doi.org/10.1057/palgrave.bm.2540284
   Google Scholar
• Chen, C. C. M., Nguyen, B., Melewar, T. C., & Dennis, C. (2017). Investigating the uses of corporate reputation and its effects on brand segmentation, brand differentiation, and brand positioning: Evidence from the Taiwanese pharmaceutical industry. International Studies of Management & Organization, 47(3), 240–257. https://doi.org/https://doi.org/10.1080/00208825.2017.1318019
   Google Scholar
• Chhabra, A., Nidhi, C., & Jain, A. (2019). Knowledge, attitudes and practice preference regarding drug prescriptions of resident dental doctors: A quantitative study. International Journal of Risk & Safety in Medicine, 30(2), 91–100. (Preprint), https://doi.org/https://doi.org/10.3233/JRS-180021
   PubMed Web of Science ®Google Scholar
• Clark, M., Vorhies, D., & Bentley, J. (2011). Relationship quality in the pharmaceutical industry: An empirical analysis. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 11(2), 144–155. https://doi.org/https://doi.org/10.1057/jmm.2010.39
   Google Scholar
• Cook, L., LaVan, H., & Zilic, I. (2018). An exploratory analysis of corporate social responsibility reporting in US pharmaceutical companies. Journal of Communication Management, 22(2), 197–211. https://doi.org/https://doi.org/10.1108/JCOM-02-2017-0020
   Web of Science ®Google Scholar
• Demir, M., & Min, M. (2019). Consistencies and discrepancies in corporate social responsibility reporting in the pharmaceutical industry. Sustainability Accounting, Management and Policy Journal, 10(2), 333–364. https://doi.org/https://doi.org/10.1108/SAMPJ-03-2018-0094
   Web of Science ®Google Scholar
• Faisal, A., Ahmad, M. S., Thurasamy, R., & Ahmed, R. (2020). Doctors’ interactions with pharmaceutical sales representatives: Modelling doctors prescription behaviour. Community Mental Health Journal, 56(3), 456–463. https://doi.org/https://doi.org/10.1007/s10597-019-00501-w
   PubMed Web of Science ®Google Scholar
• Fischer, M. A., Keough, M. E., Baril, J. L., Saccoccio, L., Mazor, K. M., Ladd, E., Von Worley, A., & Gurwitz, J. H. (2009). Prescribers and pharmaceutical representatives: Why are we still meeting? Journal of General Internal Medicine, 24(7), 795–801. https://doi.org/https://doi.org/10.1007/s11606-009-0989-6
   PubMed Web of Science ®Google Scholar
• Fombrun, C. J. (2005). Building corporate reputation through CSR initiatives: Evolving standards. Corporate Reputation Review, 8(1), 7–11. https://doi.org/https://doi.org/10.1057/palgrave.crr.1540235
   Google Scholar
• Fombrun, C., & Shanley, M. (1990). What’s in a name? Reputation building and corporate strategy. Academy of Management Journal, 33(2), 233–258. https://doi.org/https://doi.org/10.5465/256324
   Web of Science ®Google Scholar
• Geitona, M., Zavras, D., Hatzikou, M., & Kyriopoulos, J. (2006). Generics market in Greece: The pharmaceutical industry’s beliefs. Health Policy (Amsterdam, Netherlands), 79(1), 35–48. https://doi.org/https://doi.org/10.1016/j.healthpol.2005.11.004
   PubMed Web of Science ®Google Scholar
• Godin, G., Belanger-Gravel, A., Eccles, M., & Grimshaw, J. (2008). Healthcare professionals’ intentions and behaviours: A systematic review of studies based on social cognitive theories. Implementation Science, 3, 36. https://doi.org/https://doi.org/10.1186/1748-5908-3-36
   PubMed Web of Science ®Google Scholar
• Goldstein, K. (2010). Corporate Reputation Management in the Pharmaceutical Industry (p.6). June 25.
   Google Scholar
• Goldstein, K., & Doorley, J. (2011). Corporate reputation management in the U.S. pharmaceutical industry. https://pdfs.semanticscholar.org/d74b/c5ea48e64701c15073334e3dae3bac8ce04f.pdf
   Google Scholar
• Gonzalez, J., Sismeiro, C., Dutta, S., & Stern, P. (2008). Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules. International Journal of Research in Marketing, 25(4), 247–260. https://doi.org/https://doi.org/10.1016/j.ijresmar.2008.08.002
   Web of Science ®Google Scholar
• Hair, J. F., Black, W. C., Babin, B., & Anderson, R. E. (2009). Multivariate Data Analysis (7th ed.). Prentice Hall.
   Google Scholar
• Hair, J. F., Ringle, C. M., & Sarstedt, M. (2011). PLS-SEM: Indeeda silver bullet. Journal of Marketing Theory and Practice, 19(2), 139–151. https://doi.org/https://doi.org/10.2753/MTP1069-6679190202
   Google Scholar
• Han, L. Y., Arokiasamy, L., & Marn, J. T. K. (2019). The association between ethical customer management and organizational sustainability in pharmaceutical industry in Malaysia. Global Business and Management Research: An International Journal, 11(1), 607–619.
   Google Scholar
• Hogarth, K., Hutchinson, M., & Scaife, W. (2018). Corporate philanthropy. Reputation risk management and shareholder value: A study of Australian corporate giving. Journal of Business Ethics, 151(2), 375–390. https://doi.org/https://doi.org/10.1007/s10551-016-3205-8
   Web of Science ®Google Scholar
• Iglesias, O., Markovic, S., Bagherzadeh, M., & Singh, J. J. (2020). Co-creation: A key link between corporate social responsibility, customer trust, and customer loyalty. Journal of Business Ethics, 163(1), 151–166. https://doi.org/https://doi.org/10.1007/s10551-018-4015-y
   Web of Science ®Google Scholar
• Ion, L. M. (2013). Qualitative study on physicians’ motivations and drug prescribing behaviour. CES Working Papers, 5(1), 29–40.
   Google Scholar
• Jacob, N. T. (2018). Drug promotion practices: A review. British Journal of Clinical Pharmacology, 84(8), 1659–1667. https://doi.org/https://doi.org/10.1111/bcp.13513
   PubMed Web of Science ®Google Scholar
• Karayanni, D., & Georgi, C. (2007). How do physicians appreciate detailers’ personal and relational skills?—An exploratory empirical investigation. http://www.bma.upatras.gr/staff/karayan/articles/EBES2010.pdf
   Google Scholar
• Karayanni, D., & Georgi, C. (2012). Segmenting generic medicines’ market, using physicians’ attitudes and generic companies’ prescription span as grouping criteria. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 12(2), 104–120. https://doi.org/https://doi.org/10.1177/1745790412443144
   Google Scholar
• Kersnik, J., Klemenc-Ketis, Z., Petek-Ster, M., Tusek-Bunc, K., Poplas-Susic, T., & Kolsek, M. (2011). Family doctors’ views of pharmaceutical sales representatives: Assessment scale development. Family Practice, 28(4), 456–460. https://doi.org/https://doi.org/10.1093/fampra/cmq105
   PubMed Web of Science ®Google Scholar
• Kessel, M. (2014). Restoring the pharmaceutical industry’s reputation. Nature Biotechnology, 32(10), 983–984. https://doi.org/https://doi.org/10.1038/nbt.3036
   PubMed Web of Science ®Google Scholar
• Kim, S. (2019). The process model of corporate social responsibility (CSR) communication: CSR communication and its relationship with consumers’ CSR knowledge, trust, and corporate reputation perception. Journal of Business Ethics, 154(4), 1143–1159. https://doi.org/https://doi.org/10.1007/s10551-017-3433-6
   Web of Science ®Google Scholar
• Langlois, L. (2011). The anatomy of ethical leadership. University Press.
   Google Scholar
• Leiva, R., Ferrero, I., & Calderón, R. (2016). Corporate reputation in the business ethics field: Its relation with corporate identity, corporate image, and corporate social responsibility. Corporate Reputation Review, 19(4), 299–315. https://doi.org/https://doi.org/10.1057/s41299-016-0008-x
   Web of Science ®Google Scholar
• Liu, C., Liu, C., Wang, D., Deng, Z., Tang, Y., & Zhang, X. (2019). Determinants of antibiotic prescribing behaviors of primary care physicians in Hubei of China: A structural equation model based on the theory of planned behavior. Antimicrobial Resistance & Infection Control, 8(1), 23. https://doi.org/https://doi.org/10.1186/s13756-019-0478-6
   PubMed Web of Science ®Google Scholar
• Malik, M. S., & Kanwal, L. (2018). Impact of corporate social responsibility disclosure on financial performance: Case study of listed pharmaceutical firms of Pakistan. Journal of Business Ethics, 150(1), 69–78. https://doi.org/https://doi.org/10.1007/s10551-016-3134-6
   Web of Science ®Google Scholar
• Mehralian, G., Zarei, L., Akhgari, M., & Peikanpour, M. (2019). Does CSR matter in the pharmaceutical distribution industry? The balanced scorecard perspective. International Journal of Pharmaceutical and Healthcare Marketing, 13(2), 228–243. https://doi.org/https://doi.org/10.1108/IJPHM-05-2017-0028
   Web of Science ®Google Scholar
• Melé, D. (2012). Management ethics: Placing ethics at the core of good management. Palgrave Macmillan.
   Google Scholar
• Mitchell, L. (2002). Corporate Irresponsibility: America’s Newest Export. Yale University Press. 214 p.
   Google Scholar
• Newburry, W., Deephouse, D. L., & Gardberg, N. A. (2019). Global aspects of reputation and strategic management. Global Aspects of Reputation and Strategic Management (Research in Global Strategic Management, Vol. 18), 1–20. https://doi.org/https://doi.org/10.1108/S1064-485720190000018009
   Google Scholar
• Panigyrakis, G. G., & Veloutsou, C. (1999). Brand managers in the pharmaceutical industry: Are they any different? Journal of Product & Brand Management, 8(6), 497–512. https://doi.org/https://doi.org/10.1108/10610429910299737
   Google Scholar
• Pareek, B., Liu, Q., & Ghosh, P. (2019). Ask your doctor whether this product is right for you: A Bayesian joint model for patient drug requests and physician prescriptions. Journal of the Royal Statistical Society: Series A (Statistics in Society), 182(1), 197–223. https://doi.org/https://doi.org/10.1111/rssa.12365
   Web of Science ®Google Scholar
• Prentis, R., Lis, Y., & Walker, S. (1988). Pharmaceutical innovation by the Seven UK-owned pharmaceutical companies (1964–1985). British Journal of Clinical Pharmacology, 25(3), 387–396. https://doi.org/https://doi.org/10.1111/j.1365-2125.1988.tb03318.x
   PubMed Web of Science ®Google Scholar
• Renkema, E., Ahaus, K., Broekhuis, M., & Tims, M. (2019). Triggers of defensive medical behaviours: A cross-sectional study among physicians in the Netherlands. BMJ Open, 9(6), e025108. https://doi.org/https://doi.org/10.1136/bmjopen-2018-025108
   PubMed Web of Science ®Google Scholar
• Schiebel, W., & Pöchtrager, S. (2003). Corporate ethics as a factor for success–the measurement instrument of the University of Agricultural Sciences (BOKU), Vienna. Supply Chain Management: An International Journal, 8(2), 116–121. https://doi.org/https://doi.org/10.1108/13598540310468715
   Web of Science ®Google Scholar
• Schnietz, K. E., & Epstein, M. J. (2005). Exploring the financial value of a reputation for corporate social responsibility during a crisis. Corporate Reputation Review, 7 (4), 327–345. https://doi.org/https://doi.org/10.1057/palgrave.crr.1540230
   Google Scholar
• Segal, R., & Hepler, C. D. (1982). Prescribers’ beliefs and values as predictors of drug choices. American Journal of Hospital Pharmacy, 39(11), 1891–1897. https://doi.org/https://doi.org/10.1093/ajhp/39.11.1891
   PubMedGoogle Scholar
• Segal, R., & Hepler, C. D. (1985). Drug choice as a problem-solving process. Medical Care, 23(8), 967–976. https://doi.org/https://doi.org/10.1097/00005650-198508000-00004
   PubMed Web of Science ®Google Scholar
• Shahani, A., Khoso, I., & Abbasi, M. (2019). The impact of corporate reputation on building brand equity: A perspective of multinationals FMCGs. Journal of Business Strategies, 13(1), 45–58. https://doi.org/https://doi.org/10.29270/JBS.13.1(2019).073
   Google Scholar
• Shakeel, S., Nesar, S., Iffat, W., Fatima, B., Maqbool, T., & Jamshed, S. (2019). A quantitative insight of the interactions of prescribers with pharmaceutical organization’s representatives in clinical settings of Karachi. Integrated Pharmacy Research & Practice, 8, 75–83. https://doi.org/https://doi.org/10.2147/IPRP.S196318
   PubMed Web of Science ®Google Scholar
• Sharabati, A.-A. A. (2018). Effect of corporate social responsibility on Jordan pharmaceutical industry’s business performance. Social Responsibility Journal, 14(3), 566–583. https://doi.org/https://doi.org/10.1108/SRJ-12-2016-0221
   Web of Science ®Google Scholar
• Sharifnia, S. H. A., Mohammadzadeh, M., Arzani, G., Salamzadeh, J., Abolfazli, S. A., Zali, A., & Khoshdel, A. R. (2018). Main factors affecting physicians’ prescribing decisions: The Iranian experience. Iranian Journal of Pharmaceutical Research, 17(3), 1105–1115.
   PubMed Web of Science ®Google Scholar
• Stros, M., Hari, J., & Marriott, J. (2009). The relevance of marketing activities in the Swiss prescription drugs market. International Journal of Pharmaceutical and Healthcare Marketing, 3(4), 323–346. https://doi.org/https://doi.org/10.1108/17506120911006038
   Google Scholar
• The IQVIA Institute Reports. (2019). The global use of medicine in 2019 and Outlook to 2023, forecasts and areas to watch institute report. https://www.iqvia.com/insights/the-iqvia-institute/reports/the-global-use-of-medicine-in-2019-and-outlook-to-2023.
   Google Scholar
• Tomažič, T., & Čelofiga, A. K. (2019). Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions. Philosophy, Ethics, and Humanities in Medicine, 14(1), 7. https://doi.org/https://doi.org/10.1186/s13010-019-0076-5
   PubMed Web of Science ®Google Scholar
• Vodă, A. I., & Florea, N. (2019). Impact of personality traits and entrepreneurship education on entrepreneurial intentions of business and engineering students. Sustainability, 11(4), 1192. https://doi.org/https://doi.org/10.3390/su11041192
   Web of Science ®Google Scholar
• Wright, R., & Lundstrom, W. (2004). Physicians’ perceptions of pharmaceutical sales representatives: A model for analyzing the customer relationship. Journal of Medical Marketing, 4(1), 29–38. https://doi.org/https://doi.org/10.1057/palgrave.jmm.5040140
   Google Scholar
• Wu, T., & Kimura, Y. (2018). Case study of corporate social responsibility in Japanese pharmaceutical companies: A comparison with western firms. In Emerging Issues in Global Marketing (pp. 291–309). Springer.
   Google Scholar